Report Detail

Pharma & Healthcare Global Conjugated Estrogen Market Insights, Forecast to 2025

  • RnM3378178
  • |
  • 06 May, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares’ urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones.
Menopause is a natural and normal process in women, which occurs due to aging and lowers the function of ovaries and lowers the levels of estrogen and other hormones in the body. The growing prevalence of the female geriatric population and women with menopause is the major factor driving the growth of the conjugated estrogens market over the forecast period.
The global Conjugated Estrogen market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Conjugated Estrogen market based on company, product type, end user and key regions.

This report studies the global market size of Conjugated Estrogen in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Conjugated Estrogen in these regions.
This research report categorizes the global Conjugated Estrogen market by top players/brands, region, type and end user. This report also studies the global Conjugated Estrogen market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Teva Pharmaceuticals
Xi'an Sgonek Biological Technology

Market size by Product
Tablets
Creams
Powder
Market size by End User
Hospitals
Obstetrics & Gynecology Clinics
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Conjugated Estrogen market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Conjugated Estrogen market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Conjugated Estrogen companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Conjugated Estrogen submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Conjugated Estrogen are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Conjugated Estrogen market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Conjugated Estrogen Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Conjugated Estrogen Market Size Growth Rate by Product
      • 1.4.2 Tablets
      • 1.4.3 Creams
      • 1.4.4 Powder
    • 1.5 Market by End User
      • 1.5.1 Global Conjugated Estrogen Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Obstetrics & Gynecology Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Conjugated Estrogen Market Size
      • 2.1.1 Global Conjugated Estrogen Revenue 2014-2025
      • 2.1.2 Global Conjugated Estrogen Sales 2014-2025
    • 2.2 Conjugated Estrogen Growth Rate by Regions
      • 2.2.1 Global Conjugated Estrogen Sales by Regions
      • 2.2.2 Global Conjugated Estrogen Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Conjugated Estrogen Sales by Manufacturers
      • 3.1.1 Conjugated Estrogen Sales by Manufacturers
      • 3.1.2 Conjugated Estrogen Sales Market Share by Manufacturers
      • 3.1.3 Global Conjugated Estrogen Market Concentration Ratio (CR5 and HHI)
    • 3.2 Conjugated Estrogen Revenue by Manufacturers
      • 3.2.1 Conjugated Estrogen Revenue by Manufacturers (2014-2019)
      • 3.2.2 Conjugated Estrogen Revenue Share by Manufacturers (2014-2019)
    • 3.3 Conjugated Estrogen Price by Manufacturers
    • 3.4 Conjugated Estrogen Manufacturing Base Distribution, Product Types
      • 3.4.1 Conjugated Estrogen Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Conjugated Estrogen Product Type
      • 3.4.3 Date of International Manufacturers Enter into Conjugated Estrogen Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Conjugated Estrogen Sales by Product
    • 4.2 Global Conjugated Estrogen Revenue by Product
    • 4.3 Conjugated Estrogen Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Conjugated Estrogen Breakdown Data by End User

    6 North America

    • 6.1 North America Conjugated Estrogen by Countries
      • 6.1.1 North America Conjugated Estrogen Sales by Countries
      • 6.1.2 North America Conjugated Estrogen Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Conjugated Estrogen by Product
    • 6.3 North America Conjugated Estrogen by End User

    7 Europe

    • 7.1 Europe Conjugated Estrogen by Countries
      • 7.1.1 Europe Conjugated Estrogen Sales by Countries
      • 7.1.2 Europe Conjugated Estrogen Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Conjugated Estrogen by Product
    • 7.3 Europe Conjugated Estrogen by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Conjugated Estrogen by Countries
      • 8.1.1 Asia Pacific Conjugated Estrogen Sales by Countries
      • 8.1.2 Asia Pacific Conjugated Estrogen Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Conjugated Estrogen by Product
    • 8.3 Asia Pacific Conjugated Estrogen by End User

    9 Central & South America

    • 9.1 Central & South America Conjugated Estrogen by Countries
      • 9.1.1 Central & South America Conjugated Estrogen Sales by Countries
      • 9.1.2 Central & South America Conjugated Estrogen Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Conjugated Estrogen by Product
    • 9.3 Central & South America Conjugated Estrogen by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Conjugated Estrogen by Countries
      • 10.1.1 Middle East and Africa Conjugated Estrogen Sales by Countries
      • 10.1.2 Middle East and Africa Conjugated Estrogen Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Conjugated Estrogen by Product
    • 10.3 Middle East and Africa Conjugated Estrogen by End User

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Conjugated Estrogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Conjugated Estrogen Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 Teva Pharmaceuticals
      • 11.2.1 Teva Pharmaceuticals Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Teva Pharmaceuticals Conjugated Estrogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Teva Pharmaceuticals Conjugated Estrogen Products Offered
      • 11.2.5 Teva Pharmaceuticals Recent Development
    • 11.3 Xi'an Sgonek Biological Technology
      • 11.3.1 Xi'an Sgonek Biological Technology Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Xi'an Sgonek Biological Technology Conjugated Estrogen Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Xi'an Sgonek Biological Technology Conjugated Estrogen Products Offered
      • 11.3.5 Xi'an Sgonek Biological Technology Recent Development

    12 Future Forecast

    • 12.1 Conjugated Estrogen Market Forecast by Regions
      • 12.1.1 Global Conjugated Estrogen Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Conjugated Estrogen Revenue Forecast by Regions 2019-2025
    • 12.2 Conjugated Estrogen Market Forecast by Product
      • 12.2.1 Global Conjugated Estrogen Sales Forecast by Product 2019-2025
      • 12.2.2 Global Conjugated Estrogen Revenue Forecast by Product 2019-2025
    • 12.3 Conjugated Estrogen Market Forecast by End User
    • 12.4 North America Conjugated Estrogen Forecast
    • 12.5 Europe Conjugated Estrogen Forecast
    • 12.6 Asia Pacific Conjugated Estrogen Forecast
    • 12.7 Central & South America Conjugated Estrogen Forecast
    • 12.8 Middle East and Africa Conjugated Estrogen Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Conjugated Estrogen Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Global Conjugated Estrogen . Industry analysis & Market Report on Global Conjugated Estrogen is a syndicated market report, published as Global Conjugated Estrogen Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Global Conjugated Estrogen market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,104.40
      4,656.60
      6,208.80
      3,623.10
      5,434.65
      7,246.20
      600,366.00
      900,549.00
      1,200,732.00
      325,689.00
      488,533.50
      651,378.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report